Showing results (701-710 of 746) with videos related to

Sort By:
Pageof 75
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2021
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell LymphomaGrzegorz S Nowakowski, Annalisa Chiappella, Randy D Gascoyne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2025
Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)Jeff P Sharman, Talha Munir, Sebastian Grosicki, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 31, 2022
European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatmentG A Lee, S Aktaa, E Baker, et al.
The Lancet. Haematology|May 4, 2023
European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumoursCristina Nanni, Carsten Kobe, Bettina Baeßler, et al.
The Lancet. Haematology|June 18, 2024
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre studyKim M Linton, Umberto Vitolo, Wojciech Jurczak, et al.
The Lancet. Haematology|July 3, 2025
Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines CommitteeGandhi Damaj, Ali Bazarbachi, Philipp Berning, et al.
Future Oncology (London, England)|December 13, 2023
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatmentJennifer R Brown, Barbara Eichhorst, Peter Hillmen, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 3, 2022
Mitochondrial Energetics in Skeletal Muscle Are Associated With Leg Power and Cardiorespiratory Fitness in the Study of Muscle, Mobility and AgingTheresa Mau, Li-Yung Lui, Giovanna Distefano, et al.
Chemmedchem|April 3, 2026
Ligand-Induced Conformational Plasticity of the CTLH E3 Ligase Receptor GID4Daria Kotlarek, Katarzyna Dudek, Bartosz Woźniak, et al.
The Lancet. Oncology|April 13, 2021
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trialMatthew J Matasar, Marcelo Capra, Muhit Özcan, et al.
Pageof 75